Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Johnson & Johnson    JNJ   US4781601046

JOHNSON & JOHNSON (JNJ)

213
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 

Johnson & Johnson : FDA : J&J Unit Recalls Potentially Flammable Bone Putty

08/21/2012 | 06:13pm US/Eastern
Recommend:
0
   By Ben Fox Rubin 
 

The Food and Drug Administration said Johnson & Johnson (JNJ) unit Synthes last month initiated a recall on certain lots of bone putty, saying the medical product could catch fire during surgery.

The FDA gave the recall a Class I designation, its most serious type of recall.

The regulator said Synthes in early July issued a medical device recall letter, asking medical facilities to examine their inventories and immediately stop using specific lots of the putty. The product, called a hemostatic bone putty, is used to stop bone bleeding by creating a physical barrier along the edges of bones that have been damaged by trauma or cut during surgery.

The FDA said the putty could ignite under some conditions if contacted with certain surgical equipment.

The lots recalled were manufactured between July 6, 2011, and Dec. 14, 2011, and were distributed from Dec. 22, 2011, to June 25, 2012.

J&J in June completed its $19.7 billion purchase of medical-device maker Synthes. The health-care giant has worked to tackle a range of problem products, such as the bottles of children's Tylenol and other popular over-the-counter medicines, as well as some contact lenses and certain hip implants, that the company recalled due to manufacturing problems.

The company's shares closed Tuesday at $67.78 and were up 15 cents after hours. The stock is up 3.4% so far this year.

Write to Ben Fox Rubin at ben.rubin@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Recommend :
0
React to this article
Latest news on JOHNSON & JOHNSON
1d ago JOHNSON & JOHNSON : Talcum Powder Attorney Group Expands Website to Offer Talcum..
1d ago JOHNSON & JOHNSON : Janssen Affiliate Cilag GmbH International Acquires Covagen ..
1d ago JOHNSON & JOHNSON : New Report Backs Risperdal Lawsuits Purporting Gynecomastia ..
2d ago VIVUS : acquires patent rights to Qsymia ingredient
5d ago JOHNSON & JOHNSON : South Florida Personal Injury Lawyer Robert Gordon Comments ..
5d ago JOHNSON & JOHNSON : J&j to beef up skincare portfolio
5d ago JOHNSON & JOHNSON : ex-dividend day
6d ago DOW MOVERS : Ba, jnj
7d ago JOHNSON & JOHNSON : Data from Johnson & Johnson Advance Knowledge in Photodermat..
08/20 JOHNSON & JOHNSON : Quote marks
Advertisement
Chart
Duration : Period :
Johnson & Johnson Technical Analysis Chart | JNJ | US4781601046 | 4-Traders
Income Statement Evolution
Johnson _ Johnson : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF